Combination of Sintilimab and Stereotactic Body Radiotherapy in Hepatocellular Carcinoma (ISBRT01)

Clinical trial NCT04167293 · UNKNOWN

Trial details

NCT number: NCT04167293
Sponsor: Mian XI
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2019-11-16
Primary completion: 2021-11-30
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.